A. A pharmacist clinician planning to exercise prescriptive authority in practice shall have on file at the place of practice written guidelines or protocol. The guidelines or protocol shall authorize a pharmacist clinician to exercise prescriptive authority and shall be established and approved by a practitioner in accordance with regulations adopted by the board. A copy of the written guidelines or protocol shall be on file with the board. The practitioner who is a party to the guidelines or protocol shall be in active practice and the prescriptive authority that the practitioner grants to a pharmacist clinician shall be within the scope of the practitioner's current practice.

B. The guidelines or protocol required by Subsection A of this section shall include:

(1) a statement identifying the practitioner authorized to prescribe dangerous drugs and the pharmacist clinician who is a party to the guidelines or protocol;

(2) a statement of the types of prescriptive authority decisions that the pharmacist clinician is authorized to make, which may include:

(a) a statement of the types of diseases, dangerous drugs or dangerous drug categories involved and the type of prescriptive authority authorized in each case; and

(b) a general statement of the procedures, decision criteria or plan the pharmacist clinician is to follow when exercising prescriptive authority;

(3) a statement of the activities the pharmacist clinician is to follow in the course of exercising prescriptive authority, including documentation of decisions made and a plan for communication or feedback to the authorizing practitioner concerning specific decisions made. Documentation may occur on the prescriptive record, patient profile, patient medical chart or in a separate log book; and

(4) a statement that describes appropriate mechanisms for reporting to the practitioner monitoring activities and results.

C. The written guidelines or protocol shall be reviewed and shall be revised every two years if necessary.

D. A pharmacist clinician planning to exercise prescriptive authority in practice shall be authorized to monitor dangerous drug therapy.

E. The board shall adopt regulations to carry out the provisions of the Pharmacist Prescriptive Authority Act [61-11B-1 to 61-11B-3 NMSA 1978].

F. For the purpose of the Pharmacist Prescriptive Authority Act, the New Mexico medical board and the board of osteopathic medicine shall adopt rules concerning the guidelines and protocol for their respective practitioners defined in Subsection D of Section 61-11B-2 NMSA 1978.

History: Laws 1993, ch. 191, § 3; 2016, ch. 90, § 27.

The 2016 amendment, effective July 1, 2016, required the board of osteopathic medicine to adopt rules concerning the guidelines and protocol for osteopathic practitioners; in Subsection A, after "prescriptive authority in", deleted "his", after "shall have on file at", deleted "his" and added "the", and after "prescriptive authority that", deleted "he" and added "the practitioner"; in Subsection D, after "prescriptive authority in", deleted "his"; in Subsection F, after "Pharmacist Prescriptive Authority Act, the", added "New Mexico medical", after "board", deleted "of medical examiners" and added "and the board of osteopathic medicine", after "shall adopt", deleted "regulations" and added "rules", after "protocol for", added "their respective", after "Subsection", deleted "C" and added "D", and after "Section", deleted "2 of that act" and added "61-11B-2 NMSA 1978".